Northern Trust
AMLX icon

Northern Trust’s Amylyx Pharmaceuticals AMLX Stock Holding History

Northern Trust’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
831,740
+51,832
+7% +$802K ﹤0.01% 1961
2026
Q1 		$10.8M Sell
779,908
-157,856
-17% -$2.22M ﹤0.01% 2023
2025
Q4 		$11.3M Buy
937,764
+115,527
+14% +$1.57M ﹤0.01% 2011
2025
Q3 		$11.2M Buy
822,237
+2,073
+0.3% +$19.5K ﹤0.01% 2046
2025
Q2 		$5.26M Buy
820,164
+680,832
+489% +$3.31M ﹤0.01% 2437
2025
Q1 		$493K Buy
139,332
+32,768
+31% +$117K ﹤0.01% 3584
2024
Q4 		$403K Buy
106,564
+11,214
+12% +$52.8K ﹤0.01% 3734
2024
Q3 		$309K Sell
95,350
-271,899
-74% -$611K ﹤0.01% 3727
2024
Q2 		$698K Sell
367,249
-58,318
-14% -$113K ﹤0.01% 3382
2024
Q1 		$1.21M Sell
425,567
-9,870
-2% -$129K ﹤0.01% 3235
2023
Q4 		$6.41M Buy
435,437
+9,659
+2% +$148K ﹤0.01% 2356
2023
Q3 		$7.8M Sell
425,778
-59,640
-12% -$1.26M ﹤0.01% 2166
2023
Q2 		$10.5M Buy
485,418
+21,538
+5% +$582K ﹤0.01% 2035
2023
Q1 		$13.6M Buy
463,880
+68,741
+17% +$2.39M ﹤0.01% 1810
2022
Q4 		$14.6M Buy
395,139
+109,331
+38% +$3.88M ﹤0.01% 1750
2022
Q3 		$8.04M Buy
285,808
+191,267
+202% +$4.77M ﹤0.01% 2149
2022
Q2 		$1.82M Buy
94,541
+12,371
+15% +$147K ﹤0.01% 3115
2022
Q1 		$1.06M Buy
+82,170
New +$1.86M ﹤0.01% 3395

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Northern Trust's AMLX Position: Q2 2026 in Review

Northern Trust increased its Amylyx Pharmaceuticals (AMLX) stake by 6.6% in Q2 2026, buying an estimated $802K and bringing the position to 831,740 shares worth $14.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1961.

Northern Trust first reported a position in AMLX in Q1 2022 and has held it in 18 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Northern Trust held 831,740 shares of Amylyx Pharmaceuticals worth $14.9M as of Q2 2026.
  • Northern Trust bought 51,832 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $802K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1961 holding.
  • Northern Trust first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.